Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, ...

Plans to seek FDA submission and approval for first-in-human trials in type 1 diabetes and stiff person syndrome targeted for early 2026 MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Aditxt, Inc. (NASDAQ: ...

In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the ...

As people grow older, their immune systems do not simply slow down, they often become locked into a simmering, ...

British scientist says humans could live 20,000 years through DNA reprogramming and cellular repair technology that ...

For more than 30 years, scientists have studied how the myogenic determination gene number 1 (MYOD) protein binds DNA to modify the gene expression of muscle stem cells. Similar to the instant kung fu ...

Researchers have identified a new way to reprogram T cells, which are infection and tumor-fighting white blood cells, so that they have a superior memory, thereby making them more effective in killing ...

A research paper by scientists from Beijing Institute of Technology investigated the anti-tumor effect of millimeter waves (MMWs) alone and in combination with the anti-programmed cell death-ligand 1 ...

Aditxt’s Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at ...